Name	Sequence	Binding affinity & binding capacity	Human study	Ref
BBN	pGlu-Gln-Arg-Leu-Gly-Asn-Gln-Trp-Ala-Val-Gly-His-Leu-Met-NH2	IC50 = 1.36 nM (BBN), 1.8 ± 0.2 nM ([Tyr4]BBN), 3.3 ± 0.4 nM ([Lys3]-BBN), 20.8 ± 0.3(Aca-BBN(7–14))	No	[56–58]
AMBA	Gly-4-aminobenzoyl-Gln-Trp-Ala-Val-Gly-His-Leu-Met-NH2	Kd = 0.7 ± 0.1 nM (111In-DOTA-AMBA)	No	[62, 88]
RM1	Gly-4-aminobenzoyl-H–D-Phe-Gln-Trp-Ala-Val-Gly-His-Sta-Leu-NH2	IC50 = 14 ± 3.4 nM ( natIn-DOTA-RM1) Kd = 2.4 ± 0.2 nM (111In-DOTA-RM1)	No	[62, 88]
RM2	4-amino-1-carboxymethylpiperidine-D-Phe-Gln-Trp-Ala-Val-Gly-His-Sta-Leu-NH2	IC50 = 7.7 ± 3.3 nM (RM2), 9.3 ± 3.3 nM (natIn-DOTA-RM2), Kd = 2.9 ± 0.4 nM (111In-DOTA-RM2)	Yes	[63, 88]
RM26	D-Phe-Gln-Trp-Ala-Val-Gly-His-Sta-Leu-NH2	IC50 = 5.5 ± 0.4 nM (natCo-NOTA-PEG3-RM26)	Yes	[70, 88]
JMV5132	MPAA-βAla-βAla-[H–D-Phe-Gln-Trp-Ala-Val-Gly-His-Sta-Leu-NH2]	IC50 = 6.8 nM (JMV5132), 3.0 nM (natGa-NODA-JMV5132), 10.0 nM (AlnatF-NODA-JMV5132)	No	[67]
JMV4168	βAla-βAla-[H–D-Phe-Gln-Trp-Ala-Val-Gly-His-Sta-Leu-NH2]	IC50 = 13.2 nM (JMV4168), 3.2 nM (natGa-DOTA-JMV4168)	No	[67]
JMV594	H–D-Phe-Gln-Trp-Ala-Val-GlyHis-Sta-Leu-NH2	IC50 = 2.2 ± 0.1 nM (JMV594)	No	[66]
SB3	p-aminomethylaniline-diglycolicacid-D-Phe-Gln-Trp-Ala-Val-Gly-His-Leu-NHEt	IC50 = 4.6 ± 0.5 nM (SB3), 1.5 ± 0.3 nM (natGa-DOTA-SB3)	No	[69, 88]